Abundnz
Abundnz is a privately owned company founded in October 2011, specializing in advanced immunological and analytical support for biopharmaceutical companies and life sciences researchers. They develop innovative analytical techniques, conduct immunology research, and in vitro testing to characterize medicines like peptide and protein drugs, oligonucleotides, and targeted drug delivery systems. Their technology includes a platform to study drug side effects and immune responses, notably the pAMS technology for early-phase drug clearance profiling. Abundnz aims to be a reliable partner in immunology and bioanalysis projects, supporting drug discovery and research with customized solutions.
Industries
Nr. of Employees
small (1-50)
Abundnz
Noordveenweg 3c, 2376 AP NIEUWE WETERING, The Netherlands
Products
Ultra-sensitive bioanalytical assays for large molecules
Assay services and methods enabling sensitive detection and quantification of peptide, protein and oligonucleotide therapeutics for preclinical research.
In vitro immune-response prediction platform (COMPIT)
Collaborative in vitro platform developed under a Eurostars project to evaluate and predict the human immune response to pharmaceuticals.
Ultra-sensitive bioanalytical assays for large molecules
Assay services and methods enabling sensitive detection and quantification of peptide, protein and oligonucleotide therapeutics for preclinical research.
In vitro immune-response prediction platform (COMPIT)
Collaborative in vitro platform developed under a Eurostars project to evaluate and predict the human immune response to pharmaceuticals.
Services
In vitro immunology studies and immune-response testing to assess drug-induced immunological effects.
Contract bioanalytical testing supporting quantification and characterization of therapeutic molecules.
Assays for determining clearance profiles of innovative medicines in early development using AMS-based and related techniques.
Analytical characterisation of peptides, proteins, oligonucleotides and targeted delivery systems.
Analytical data processing, chemometric analysis and computational support for interpretation of assay and instrument data.
Short-term project support, expert consultancy and training in analytical methods, immunology research and bioanalysis.
In vitro immunology studies and immune-response testing to assess drug-induced immunological effects.
Contract bioanalytical testing supporting quantification and characterization of therapeutic molecules.
Assays for determining clearance profiles of innovative medicines in early development using AMS-based and related techniques.
Analytical characterisation of peptides, proteins, oligonucleotides and targeted delivery systems.
Analytical data processing, chemometric analysis and computational support for interpretation of assay and instrument data.
Short-term project support, expert consultancy and training in analytical methods, immunology research and bioanalysis.
Expertise Areas
- Immunology research and in vitro immune-response testing
- Bioanalysis for large-molecule therapeutics
- Biomarker discovery and validation
- Pharmacokinetics and clearance profiling
Key Technologies
- Accelerator mass spectrometry (AMS)
- Ultra-sensitive immunoassays
- Mass spectrometry-based bioanalysis
- Chromatography and separation techniques
News & Updates
A Eurostars project focused on immune response analysis has been successfully completed.
Participation in the BioEurope Spring 2018 event in Amsterdam.
Participated in the category of Health and Public Service at the Accenture Innovation Awards 2012.
A Eurostars project focused on immune response analysis has been successfully completed.
Participation in the BioEurope Spring 2018 event in Amsterdam.
Participated in the category of Health and Public Service at the Accenture Innovation Awards 2012.